Purchase Order 75D30120P07590
- Not listed
- The U.S. Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania awarded a $190,699.20 firm fixed price purchase order to Bionique Testing Laboratories LLC, doing business as Bionique, for mycoplasma testing services. Bionique has provided these specialized diagnostic testing services to the CDC over multiple years to support the agency's infectious disease prevention and control programs. The contract has an ultimate completion date of September 17, 2024. No set-aside...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $145,252.00 firm-fixed-price purchase order contract to Bioniquest Lab Services, Inc., a for-profit subchapter S corporation. The contract, called BIONIQUEST, is for equipment maintenance services to support federal research and healthcare programs. Services include preventative maintenance, breakdown response, diagnostics, critical part replacements, and software support for laboratory instruments...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a purchase order to Bioreliance Corporation's Life Sciences Services Division for $237,266.00 to provide laboratory services, including sterility testing. This firm fixed price contract has a completion date of September 18, 2023. Bioreliance, a foreign-owned for-profit organization, will provide sterility testing using direct inoculation methods, Limulus Amebocyte Lysate (LAL) testing...
- This federal contract award is for BIOFIRE LAB SUPPLIES, valued at $132,525.00, awarded to Biofire Diagnostics LLC, a foreign-owned, for-profit biotech company, by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is a firm-fixed price purchase order with an award date of September 17, 2019 and a completion date of October 16, 2019. No set-aside designation was used. Biofire Diagnostics LLC is a leader in syndromic...
- This is a definitive contract award to Bioreliance Corporation, a foreign-owned, for-profit organization, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The $672,262.42 firm-fixed-price contract is for BIORELIANCE EXPI293F services, which likely includes specialized microbiological and scientific testing capabilities to support pharmaceutical and biotechnology research, such as endotoxin testing, sterility testing, and Limulus Amebocyte Lysate (LAL) testing. The...
- This federal contract award, valued at $248,779.00, was issued by the Centers for Disease Control and Prevention (CDC) to Bioreliance Corporation, a foreign-owned, for-profit organization, to conduct follow-up testing for tumorigenicity and oncogenicity on the Master Cell Bank (MCB) of Expi293F cells. The contract is a firm-fixed-price purchase order with a completion date of September 24, 2026. The original sources sought notice indicates that the CDC Influenza Division requires cGMP-grade cell...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a firm fixed-price purchase order valued at $11,973.13 to Biomerieux Inc. on August 20, 2024, with a completion date of September 11, 2024. The contract procures Nuclisens reagents designed for use on Biomerieux's validated sample extraction platforms, including the Nuclisens EasyMag, eMAG, and miniMAG systems. These platforms support HIV drug resistance testing and surveillance operations conducted by the Molecular...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Bioniquest Lab Services, Inc., a for-profit subchapter S corporation. The contract is for the maintenance and support of Beckman Coulter and Sorvall analytical laboratory instrumentation, including preventative maintenance, breakdown response, diagnostics, part replacements, and software support. The potential value of the contract is...
- This $3,271,440.00 firm-fixed-price definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Biomerieux Inc., a global in vitro diagnostics company, for BIONUMERICS SUPPORT services. The contract has a period of performance through July 31, 2025 and does not involve any set-aside designations. Biomerieux Inc., through its Biomerieux, Inc. division, is a leading provider of specialized clinical diagnostic equipment, reagents, and supplies to various federal...
- The U.S. government's Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base awarded a Blanket Purchase Agreement (BPA) call to Biomerieux Inc., a global leader in in vitro diagnostics, for the procurement of BioMérieux test kits and reagents. The $16,081.23 firm-fixed-price contract has an ultimate completion date of October 18, 2022. Biomerieux Inc., through its Biomerieux, Inc. Division, specializes in microbiological testing solutions for medical, food safety, and...
Bionique Testing Laboratories LLC was awarded a firm fixed price purchase order valued at $68,826 by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. The contract is for mycoplasma testing laboratory services to support CDC infectious disease prevention and control programs. Bionique Testing Laboratories will utilize its laboratory facilities located in Saranac Lake, New York to provide the specialized diagnostic testing. No set aside designation or subcontractors were indicated for this contract award. Bionique Testing Laboratories is a foreign owned, for-profit organization that specializes in mycoplasma testing for biological products and raw materials using traditional culture based methods, real time PCR assays, and other technologies. Previous purchase orders have also been awarded by the National Institutes of Health Clinical Center for similar mycoplasma testing services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($9k) | 2/29/24 | |
| Not listed | Not listed | $68.8k | 3/20/20 |